Farmingdale, NY · Founded 2014 · Privately Held (backing)
Developer of potent inhibitors of the enzyme designed to offer therapeutics for cancer and rare diseases. DepYmed is based in Farmingdale, NY and was founded in 2014. Its last reported valuation was $36.3 million in Apr 2021. It has raised $14.3 million across 6 recorded rounds; the latest was a $250,000 seed round in Apr 2025.
Last reported valuation
$36.3M
Oct 2026
Priced at
—
Total raised
$14.3M
Last round
Seed Round
Apr 2025
Team — not yet on record
No current team members for DepYmed are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of DepYmed with a free account
·Watch DepYmed: the Monday email on marks, rounds and moves
